Microbix Biosystems Operating Income Over Time
| MBX Stock | CAD 0.24 0.01 4.00% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Microbix Biosystems Performance and Microbix Biosystems Correlation. Microbix |
Cross Equities Operating Income Analysis
Compare Microbix Biosystems and related stocks such as Resverlogix Corp, Briacell Therapeutics, and Rubicon Organics Operating Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RVX | (39.2 K) | (24.8 M) | (34.6 M) | (14 M) | (8.5 M) | (20 M) | (34.1 M) | (30.9 M) | (38.7 K) | (22.6 M) | (14.6 K) | (16 M) | (12.7 M) | (6.2 M) | (6.4 M) | (5.7 M) | (6 M) |
| BCT | (8.6 K) | (558.8 K) | (424.3 K) | (437.3 K) | (1.4 M) | (1.7 M) | (2.6 M) | (5 K) | 946.4 K | (3.9 M) | (7 M) | (15.3 M) | (23.3 M) | (46 K) | (37.7 M) | (34 M) | (32.3 M) |
| ROMJ | (5.6 M) | (5.6 M) | (5.6 M) | (5.6 M) | (5.6 M) | (5.6 M) | (5.6 M) | (5.6 M) | (12.6 M) | (9.6 M) | (12 M) | (13.3 M) | (2.6 M) | (1.1 M) | (1.2 M) | (1.3 M) | (1.4 M) |
| CWEB | 980 K | 980 K | 980 K | 980 K | 980 K | 980 K | 980 K | 12 M | 15 M | (24.8 M) | (51.3 M) | (147.1 M) | (52.5 M) | (40.6 M) | (32 M) | (28.8 M) | (30.2 M) |
| ADK | (3.1 M) | (2.2 M) | (2.1 M) | (1.6 M) | (2.7 M) | (2.7 M) | (2 M) | (2.9 M) | (2.9 M) | (2.7 M) | (2 M) | (2.6 M) | (2.2 M) | (2.6 M) | (3.8 M) | (3.4 M) | (3.3 M) |
| LABS | (213.5 K) | (213.5 K) | (213.5 K) | (213.5 K) | (213.5 K) | (213.5 K) | (133.9 K) | (948 K) | (8 M) | 6.9 M | (72.6 M) | (48.9 M) | (29.5 M) | (18.3 M) | (10.8 M) | (9.7 M) | (10.2 M) |
Microbix Biosystems and related stocks such as Resverlogix Corp, Briacell Therapeutics, and Rubicon Organics Operating Income description
Operating Income is the amount of profit realized from Microbix Biosystems operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Microbix Biosystems is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| Microbix Biosystems | MBX |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | 265 Watline Avenue, |
| Exchange | Toronto Exchange |
CAD 0.24
Other Information on Investing in Microbix Stock
Microbix Biosystems financial ratios help investors to determine whether Microbix Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Microbix with respect to the benefits of owning Microbix Biosystems security.